文献速递慢性肾脏病遗传性与小管间质肾病

ADPKD肾脏体积与分子过程呈动态变化

Kidney Volume and Molecular Processes are Dynamic in ADPKD.
PubMed 文献 · Kidney Int Rep · 2026-02-25

研究在大型ADPKD队列中分析肾脏体积随分类和年龄的变化,并对Pkd1 RC/RC与野生型小鼠纵向研究肾脏体积、功能及不同阶段mRNA测序。发现多数患者肾脏体积持续增长但速率因分类和年龄而异,小鼠转录组随病程演变且与人类ADPKD相关,提示不同疾病阶段可能适用不同治疗策略。

要点

  • ADPKD患者肾脏体积多数持续增长,但增速因分类和年龄不同。
  • Pkd1 RC/RC小鼠肾脏体积和功能变化与1C类成人患者相符。
  • 小鼠肾脏转录组随病程动态演变,与人类ADPKD相关。

核心结论

  • ADPKD中不同疾病阶段可能适合不同治疗策略,并识别了可用于生物标志物发现的候选通路。

研究设计与样本

  • 在大型、特征明确且长期随访的ADPKD个体队列中按分类和年龄确定肾脏体积变化。
  • 对Pkd1 RC/RC和野生型小鼠进行纵向研究,分析肾脏体积变化和功能。
  • 对Pkd1 RC/RC小鼠早期、中期和晚期肾脏mRNA进行测序,并与其他ADPKD模型和人类ADPKD比较。

主要发现

  • 多数ADPKD个体肾脏体积持续增加,但增长率在分类之间以及严重分类内随年龄不同。
  • Pkd1 RC/RC小鼠成年期肾脏体积和功能变化与1C类患者肾脏体积变化高度一致。
  • Pkd1 RC/RC小鼠肾脏转录组随疾病进程演变,与其他ADPKD模型有共同点并与人类ADPKD相关。

临床怎么用

  • 临床中应认识到ADPKD肾脏体积增长速率随分类和年龄变化,评估需结合分类与年龄。
  • 不同疾病阶段可考虑不同治疗策略,并关注病程动态的分子通路。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Although progress has been made toward elucidating cellular pathways related to initial cystogenesis in autosomal dominant polycystic kidney disease (ADPKD), the mechanisms that contribute to disease progression and the timing of transitions remain largely unclear. We hypothesized that the predominant kidney biological processes in Pkd1 RC/RC and other ADPKD models are highly dynamic throughout the disease, providing insights into the resulting kidney phenotype and conform well to those observed in human ADPKD. METHODS: Kidney volume changes by class and age were determined in a large, well-characterized cohort of individuals with ADPKD and long follow-up. Similarly, Pkd1 RC/RC and wild-type (WT) mice were studied longitudinally, and their kidney volume changes and function analyzed. Kidney mRNA profiles (mRNA-sequencing [mRNA-seq]) of Pkd1 RC/RC mice were investigated at early, mid, and late stages, compared with those reported in other ADPKD models and humans with ADPKD. RESULTS: In most individuals with ADPKD, kidney volume continues to increase; however, the rate of growth differs between classes and within severe classes by age. Kidney volume and function changes in Pkd1 RC/RC mice conform well to the kidney volume changes in class 1C patients during adulthood. The kidney transcriptomic profile in Pkd1 RC/RC mice evolves over the course of the disease, underscoring their highly dynamic kidney phenotype, presents several commonalities with other ADPKD models, and is relevant to human ADPKD. CONCLUSION: Our study suggests that, in ADPKD, different therapeutic strategies might be beneficial at different disease stages and identifies target candidate pathways for biomarker discovery that could be further investigated in humans.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Tug A, Zheng J, Alsawaf Y, et al. Kidney Volume and Molecular Processes are Dynamic in ADPKD. Kidney Int Rep. 2026. PMID: 42058116. doi:10.1016/j.ekir.2026.106376

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。